Cargando…

Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy

BACKGROUND: To assess correlation of pretreatment specific growth rate (SGR) value of 0.43 × 10(‐2) with overall and failure‐free survival of patients with early‐stage non‐small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT). METHODS: A retrospective chart review of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atallah, Soha, Le, Lisa W., Bezjak, Andrea, MacRae, Robert, Hope, Andrew J., Pantarotto, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812066/ https://www.ncbi.nlm.nih.gov/pubmed/33258301 http://dx.doi.org/10.1111/1759-7714.13744

Ejemplares similares

Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
por: Pathak, Rima S., et al.
Publicado: (2019)

142: Virtual Care Uptake in Radiation Medicine: Lessons Learned from the COVID-19 Pandemic
por: Renaud, Julie, et al.
Publicado: (2021)

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer
por: Holmes, Oliver Edwin, et al.
Publicado: (2017)

146: COVID-19 Pandemic Impact on Radiation Treatment Delivery Metrics
por: Renaud, Julie, et al.
Publicado: (2021)

Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
por: Harris, Alexander A, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Patients with Heavily Pretreated Liver Metastases and Liver Tumors
por: Lanciano, Rachelle, et al.
Publicado: (2012)

149: Do Virtual Ro Consults Expedite Treatment? Another Tale from the COVID-19 Pandemic
por: Renaud, Julie, et al.
Publicado: (2021)

114: Quality Assurance of Radiotherapy During the COVID-19 Pandemic: Impact on Peer Review in 14 Regional Cancer Centres Across Ontario
por: Locke, Gordon, et al.
Publicado: (2021)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy
por: Hirose, Taka-aki, et al.
Publicado: (2020)

Improving Quality Metrics in Radiation Oncology: Implementation of Pretreatment Peer Review for Stereotactic Body Radiation Therapy in Patients with Thoracic Cancer
por: Kut, Carmen, et al.
Publicado: (2022)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
por: Horne, Zachary D, et al.
Publicado: (2014)

Quality Assurance of Radiotherapy During the Covid-19 Pandemic: Impact on Peer Review in 14 Regional Cancer Centers Across Ontario
por: Locke, G., et al.
Publicado: (2021)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer
por: Miura, Hideharu, et al.
Publicado: (2015)

Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost
por: Phuong, Christina, et al.
Publicado: (2022)

3’-Deoxy-3’-(18F) Fluorothymidine Positron Emission Tomography/Computed Tomography in Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy: A Pilot Study
por: Lewis, Shirley, et al.
Publicado: (2022)

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results
por: Bijlani, Akash, et al.
Publicado: (2013)

Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
por: Taremi, Mojgan, et al.
Publicado: (2012)

Stereotactic Body Radiation Therapy for Spinal Malignancies
por: Osborn, Virginia W., et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy versus Surgical Resection for Stage I/II Hepatocellular Carcinoma
por: Birgin, Emrullah, et al.
Publicado: (2023)

Pretreatment (18)F-fluorodeoxyglucose Uptake in the Lung Parenchyma Predicts Poor Survival After Stereotactic Body Radiation Therapy in Patients With Stage I Non-Small Cell Lung Cancer
por: Satoh, Yoko, et al.
Publicado: (2018)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases
por: Chan, Matthew, et al.
Publicado: (2020)

Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
por: Yamamoto, Takaya, et al.
Publicado: (2015)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Surgical ablation after stereotactic body radiation therapy for ventricular arrhythmias
por: Hayase, Justin, et al.
Publicado: (2021)

Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
por: Solberg, Timothy D., et al.
Publicado: (2012)

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014)

Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer
por: Rana, Zaker, et al.
Publicado: (2015)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Stereotactic body radiation therapy in the treatment of ovarian cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2020)

Stereotactic body radiation therapy for an octogenarian with pulmonary carcinosarcoma
por: Huang, Wei‐Lun, et al.
Publicado: (2021)

Adrenal Pheochromocytoma Treated With Stereotactic Body Radiation Therapy
por: González, Iván D, et al.
Publicado: (2021)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early‐stage prostate cancer
por: Xiang, Hong F., et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)

Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Taylor, James M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p500j5pflhj5s1lr6e387fdh9n